Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025
As investors head into the Tuesday, November 25 session, Pfizer Inc. remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that a new growth story is taking shape around obesity drugs, oncology and a large – and growing – dividend. As of late Monday trading, Pfizer shares were changing hands around $25 per share, giving the company a market value of roughly $143 billion and placing the stock in the middle of its 52‑week range between $20.92 and $27.69.StockAnalysis+1 At that price, Pfizer’s annual dividend of $1.72 per share implies a yield of about 6.8%, one of the richest payouts in big pharma.StockAnalysis+1